Abstract:Background: Ubiquitin-conjugating enzyme 2T (UBE2T) has been reported to be associated with uncontrolled cell growth and tumorigenesis in multiple cancer types. However, the understanding of its regulatory role in the carcinogenesis of Head And Neck Squamous Cell Carcinoma (HNSC) is limited. background: Ubiquitin-conjugating enzyme 2T (UBE2T) has been associated with uncontrolled cell growth and tumorigenesis in multiple cancer types. Methods: UBE2T expression in HNSC patient samples and the correlation between its expression and patients’ survival rates were evaluated using The Cancer Genome Atlas (TCGA) database. Cell survival and proliferation were investigated in UM-SCC1 and UM-SCC15 cells infected with control and shUBE2T lentivirus. The xenograft mouse model was established using UM-SCC15 cells to examine HNSC tumorigenesis with or without UBE2T. Western blot, qRT-PCR, and ferroptosis assays were carried out to disclose the interaction between UBE2T and NF-κB signaling and ferroptosis. objective: To study the understanding of its regulatory role in the carcinogenesis of head and neck squamous cell carcinoma (HNSC). Results: The increased expression of UBE2T was noted in tumor tissues of patients with HNSC, correlating with a significantly reduced overall survival time in this patient cohort. Knockdown of UBE2T inhibited HNSC tumorigenesis and tumor growth. Mechanistically, inhibition of UBE2T suppressed NF-κB signaling and induced ferroptosis in HNSC. method: UBE2T expression in HNSC patient samples and the correlation between its expression and patients’ survival rates were evaluated using TCGA database. Cell survival and proliferation were investigated in UM-SCC1 and UM-SCC15 cells infected with control and shUBE2T-derived lentivirus. Cell line-derived xenograft mouse model was established using UM-SCC15 cells to examine HNSC tumorigenesis with or without UBE2T. Western blot, qRT-PCR, and ferroptosis assays were carried out to disclose the interaction between UBE2T and NF-κB signaling and ferroptosis. Conclusion: Our study underscores the multifaceted role of UBE2T in HNSC, illuminating its potential as a biomarker and therapeutic target. result: High expression of UBE2T were consistently observed in HNSC tumor tissues, which correlated with a significantly shortened overall survival time among HNSC patients. Knockdown of UBE2T inhibited HNSC tumorigenesis and tumor growth. Mechanistically, inhibition of UBE2T suppressed NF-κB signaling activation and induced ferroptosis in HNSC.

NUCB2 promotes hepatocellular carcinoma cell growth and metastasis by activating the E2F4/PTGR1 axis

NUF2 Drives Cholangiocarcinoma Progression and Migration Via Inhibiting Autophagic Degradation of TFR1

High NUCB2 Expression Level is Associated with Metastasis and May Promote Tumor Progression in Colorectal Cancer

High Expression of NUCB2 Promotes Papillary Thyroid Cancer Cells Proliferation and Invasion

Abnormal upregulation of NUBP2 contributes to cancer progression in colorectal cancer

Nucleobindin 2 (Nucb2) In Renal Cell Carcinoma: A Novel Factor Associated With Tumor Development

NR1D2 Accelerates Hepatocellular Carcinoma Progression by Driving the Epithelial-to-Mesenchymal Transition

HNRNPU promotes the progression of hepatocellular carcinoma by enhancing CDK2 transcription

TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway

NEK2 Promotes Hepatocellular Carcinoma Migration and Invasion Through Modulation of the Epithelial-Mesenchymal Transition.

A Novel Function of NUCB2 in Promoting the Development and Invasion of Renal Cell Carcinoma

UBE2C Functions as a Potential Oncogene by Enhancing Cell Proliferation, Migration, Invasion and Drug Resistance in Hepatocellular Carcinoma Cells.

Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis

The activation of the Notch signaling pathway by UBE2C promotes the proliferation and metastasis of hepatocellular carcinoma

UBE2M Promotes Cell Proliferation Via the Β-Catenin/cyclin D1 Signaling in Hepatocellular Carcinoma

LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma

UBN2 Promotes Tumor Progression Via the Ras/MAPK Pathway and Predicts Poor Prognosis in Colorectal Cancer

Alternatively Activated NUSAP1 Promotes Tumor Growth and Indicates Poor Prognosis in Hepatocellular Carcinoma.

High NUCB2 Expression Level Represents an Independent Negative Prognostic Factor in Chinese Cohorts of Non-Metastatic Clear Cell Renal Cell Carcinoma Patients

Overexpression of hnRNPC2 induces multinucleation by repression of Aurora B in hepatocellular carcinoma cells.

NRBP2 Overexpression Inhibits Cell Proliferation and Migration and Increases Cisplatin Sensitivity in Intrahepatic Cholangiocarcinoma